Genetic Privacy and Research in Oregon: A Forum for Institutional Review Boards and Researchers - PowerPoint PPT Presentation

1 / 30
About This Presentation
Title:

Genetic Privacy and Research in Oregon: A Forum for Institutional Review Boards and Researchers

Description:

Genetic Privacy and Research in Oregon: A Forum for Institutional Review Boards and Researchers ... Comparison of Oregon and Federal Law: HIPAA (Federal ... – PowerPoint PPT presentation

Number of Views:309
Avg rating:3.0/5.0
Slides: 31
Provided by: ANEW
Category:

less

Transcript and Presenter's Notes

Title: Genetic Privacy and Research in Oregon: A Forum for Institutional Review Boards and Researchers


1
Genetic Privacy and Research in Oregon A Forum
for Institutional Review Boards and Researchers
  • August 15, 2003
  • Oregon Health Science University,
  • Oregon Dept of Human Services,
  • Advisory Committee on Genetic Privacy and
    Research (ACGPR)

2
Presented by
  • ACGPR Co-Chairs
  • Ted Falk, JD, PhD
  • Astrid Newell, MD (DHS)
  • ACGPR Members/Participants
  • Kara Manning, PhD (OHSU)
  • Emily Harris, PhD (Kaiser)
  • Kerry Silvey, MA, CGC (OHSU-CDRC)

3
Genetic Privacy in Oregon Historical Background
  • Early-1990s
  • concern about genetic privacy and potential
    discrimination
  • 1995
  • Genetic Privacy Act genetic information as
    personal property

4
Historical Background
  • 1999
  • Genetic Research Advisory Committee reviews
    property clause
  • 2001
  • Advisory Committees consensus bill passed

5
Senate Bill 114 (2001)
  • Removed property clause
  • Set civil and criminal penalties
  • Provision for anonymous genetic research
  • Established ACGPR

6
Senate Bill 618 (2003)
  • Delays effective date of some 2001 provisions
  • Anonymous research
  • Adds
  • Provisions for coded research
  • Transition clause
  • Language to conform to HIPAA
  • Sets ACGPR agenda for 03-05

7
Current Law Key Components
  • Defines individual rights regarding personal
    genetic material
  • Regulates obtaining, retaining and disclosing
    genetic information
  • Pertains to research, insurance, employment and
    clinical care settings

8
Key Concepts
  • Obtaining ?Collecting sample, getting test
    result
  • Retaining? Storing sample, recording results in a
    record
  • Disclosing?Sharing results with a third party

9
Overview of Law--Relationship to Federal Rules
  • HIPAA Federal Privacy Rule
  • Common Rule Federal Rules to Protect Human
    Subjects of Research
  • State laws may add more protection (i.e.,
    Oregon)
  • States may not reduce federal protections
  • Attempt to reconcile Oregon law with federal laws

  • Questions remain open

10
Comparison of Oregon and Federal Law The Common
Rule
11
Comparison of Oregon and Federal Law HIPAA
(Federal Privacy Rule)
12
Advisory Committee on Genetic Privacy and Reseach
  • 14 member committee
  • Appointed by
  • Assistant Director of DHS-HS
  • Senate President/House Speaker
  • Multi-disciplinary expertise

13
Advisory Committee Charge
  • Rules to implement genetic privacy act
  • Provide expertise on genetic policy issues
  • Address specific issues and report back to
    legislature

14
Advisory Committee Guiding Principles
  • Protect individual and family privacy
  • Prevent misuse of personal genetic information
  • Keep legal environment in Oregon friendly to
    genetic research

15
Issues Advisory Committee Considers
  • On our agenda
  • Privacy
  • Research
  • Discrimination
  • Consent
  • Not on our agenda
  • Cloning
  • Stem cell research
  • Law enforcement

16
Whats Special About Genetic Research in Oregon?
  • Informed consent
  • Anonymous research
  • Coded research
  • Recontact of research subjects

17
Informed Consent(ORS 192.535 192.547)
  • Need for consent and type of consent depends on
  • Identifiability of research subject
  • Date that sample was collected

18
Consent Definitions
  • Blanket consent ?sample may be used for
    research
  • Specific consent ? sample may be used for
    genetic research
  • Includes genetic research generally (or)
    particular genetic research project

19
Consent Requirements
20
Anonymous Research(ORS 192.537 OAR
333-025-0120)
  • Notification and Opt-Out Provision
  • Notify that sample may be used for anonymous
    genetic research, give opportunity to opt-out,
    document
  • New effective date ?June 12, 2003
  • Researcher responsible for assuring
  • notification has been done
  • NOT EXEMPT FROM IRB REVIEW!

21
Coded Research(ORS 192.547(5))
  • De-identification
  • Similar to HIPAA for limited
  • data set
  • Consent Requirements
  • Samples obtained on or before
  • June 12, 2003 ? consent not required
  • Samples after June 12, 2003 ?
  • specific informed consent is required
  • IRB Approval

22
Recontact (ORS 192.537(8) OAR 333-025-0130)
  • No disclosure of genetic research results to
    subjects allowed unless
  • Subject was informed prior to study (OR)
  • Researcher and IRB determine compelling reason
    for recontact/disclosure (AND)
  • Subject wishes to have information disclosed at
    time of recontact
  • Requires IRB approval

23
DISCUSSION
24
Institutional Review Boards
  • IRB Registry
  • IRB review of all genetic research studies

25
How Do Researchers and IRBs Determine if a Study
is Genetic Research?
  • Definitions
  • Genetic information derived from a genetic test
    (e.g., DNA, RNA, proteins, chromosomes)
  • Genetic research research involving genetic
    materials or genetic information

26
Is It Genetic Research?
  • Medical records reviews
  • Studies of individuals with genetic diagnoses
  • Health services

27
How Do Researchers and IRBs Handle Special
Situations?
  • Deceased subjects
  • Consent for genetic
  • research not waived
  • Next of kin may consent
  • Minor subjects
  • Not covered specifically in law
  • Oregon consent rules for teens
  • Potential harm from predictive testing

28
Special SituationsTissue Banks/Stored Samples?
  • New provisions allow coded or anonymous research
    on unconsented samples obtained prior to June 12,
    2003 (with IRB approval)
  • What needs to be included on consent forms for
    new samples?
  • Future undefined research
  • Coded vs. identified research

29
Issues
  • Are there other problematic components of the
    law/rules?
  • Need for additional information/ resources?
  • Ideas for future IRB/
  • researcher input into policy development?

30
Contact Information
Ted Falk, J.D., Ph.D. tedfalk_at_teleport.com (503)
939-5365
  • Astrid M. Newell, M.D.
  • Medical Consultant State Genetics Program
    Manager
  • Oregon Dept of Human Services,
  • Office of Family Health
  • astrid.marie.newell_at_state.or.us
  • (503) 872-6757 or (503) 731-4021
Write a Comment
User Comments (0)
About PowerShow.com